| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale/ULP, F-67404 Illkirch cedex, C. U. de Strasbourg [R. R., K. C., K. W., S. d. M.], and Laboratoire de Biologie Tumorale, Centre Paul Strauss, F-67085 Strasbourg cedex [D. M., J. A.], France
Low-grade head and neck squamous cell carcinomas without lymph node involvement or distant metastasis (N0M0) were screened for chromosomal imbalances by comparative genomic hybridization (CGH). pT1-2 tumors contain a low number of aberrations (average number, 4.3; 15 cases), in contrast to pT3 tumors (average number, 11.8; 6 cases), and exhibit a specific CGH pattern, affecting three chromosomes: partial or total 3q gain and/or 3p loss (73% of cases), 8q gain (47%), and 11q13 gain (27%). Thus, these changes represent early events in the pathogenesis of low-grade tumors. Cytogenetic exploration of chromosome 3 aberrations in head and neck cell lines suggests that the formation of an isochromosome 3q is one intermediate mechanism leading to 3p losses and/or 3q gains. On the long arm of chromosome 3, most of tumors exhibit low-level gains of large segments, involving systematically the 3q26-qter area, but with two alternative smallest region overlaps at 3q26 and 3q28-qter. We decided to refine the mapping of 3q26-qter gains by using fluorescence in situ hybridization on tumor nuclei, with clones containing two outstanding positional and functional candidate genes, PIK3CA and p63, located respectively at 3q26 and at 3q28. Although PIK3CA or p63 were preferentially gained in few cases (4 of 45), both genes were over-represented in 27 of 45 low-grade N0M0 carcinomas analyzed by CGH or fluorescence in situ hybridization. To evaluate the relative contribution of PIK3CA and p63 in the pathogenesis of head and neck carcinomas displaying a 3q gain, we measured their respective transcription levels in tumors with previously determined gene copy number. DNp63, the predominant p63 transcript, is overexpressed in tumors compared with normal tissues, but its expression level is independent to gene copy number. In contrast, a significant PIK3CA overexpression is associated with increased gene dosage. These results indicate that PIK3CA, contrary to DNp63, may participate to the progression of head and neck tumors consequent to a low-level 3q over-representation. Interestingly, survival analysis using CGH suggested, in accordance with previous data, that 3q26 gain, the locus of PIK3CA, could predict clinical outcome for early disease tumors. This prompts us to pursue 3q26 (or PIK3CA) prognostic evaluation in a larger population of head and neck squamous cell carcinomas.
This article has been cited by other articles:
![]() |
G. B. van den Broek, V. B. Wreesmann, M. W.M. van den Brekel, C. R.N. Rasch, A. J.M. Balm, and P. H. Rao Genetic Abnormalities Associated with Chemoradiation Resistance of Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., August 1, 2007; 13(15): 4386 - 4391. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pelosi, B. Del Curto, M. Trubia, A. G. Nicholson, M. Manzotti, G. Veronesi, L. Spaggiari, P. Maisonneuve, F. Pasini, A. Terzi, et al. 3q26 Amplification and Polysomy of Chromosome 3 in Squamous Cell Lesions of the Lung: A Fluorescence In situ Hybridization Study Clin. Cancer Res., April 1, 2007; 13(7): 1995 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sarkaria, P. O-charoenrat, S. G. Talbot, P. G. Reddy, I. Ngai, E. Maghami, K. N. Patel, B. Lee, Y. Yonekawa, M. Dudas, et al. Squamous Cell Carcinoma Related Oncogene/DCUN1D1 Is Highly Conserved and Activated by Amplification in Squamous Cell Carcinomas Cancer Res., October 1, 2006; 66(19): 9437 - 9444. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J.C. Slebos, Y. Yi, K. Ely, J. Carter, A. Evjen, X. Zhang, Y. Shyr, B. M. Murphy, A. J. Cmelak, B. B. Burkey, et al. Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., February 1, 2006; 12(3): 701 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Isakoff, J. A. Engelman, H. Y. Irie, J. Luo, S. M. Brachmann, R. V. Pearline, L. C. Cantley, and J. S. Brugge Breast Cancer-Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells Cancer Res., December 1, 2005; 65(23): 10992 - 11000. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Amornphimoltham, V. Patel, A. Sodhi, N. G. Nikitakis, J. J. Sauk, E. A. Sausville, A. A. Molinolo, and J. S. Gutkind Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck Cancer Res., November 1, 2005; 65(21): 9953 - 9961. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Patmore, L. Cawkwell, N. D. Stafford, and J. Greenman Unraveling the Chromosomal Aberrations of Head and Neck Squamous Cell Carcinoma: A Review Ann. Surg. Oncol., October 1, 2005; 12(10): 831 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Wreesmann, W. Shi, H. T. Thaler, A. Poluri, D. H. Kraus, D. Pfister, A. R. Shaha, J. P. Shah, P. H. Rao, and B. Singh Identification of Novel Prognosticators of Outcome in Squamous Cell Carcinoma of the Head and Neck J. Clin. Oncol., October 1, 2004; 22(19): 3965 - 3972. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Guan, J. M-W. Fung, N.-F. Ma, S.-H. Lau, L.-S. Tai, D. Xie, Y. Zhang, L. Hu, Q.-L. Wu, Y. Fang, et al. Oncogenic Role of eIF-5A2 in the Development of Ovarian Cancer Cancer Res., June 15, 2004; 64(12): 4197 - 4200. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Masayesva, P. Ha, E. Garrett-Mayer, T. Pilkington, R. Mao, J. Pevsner, T. Speed, N. Benoit, C.-S. Moon, D. Sidransky, et al. Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression PNAS, June 8, 2004; 101(23): 8715 - 8720. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Massion, P. M. Taflan, S. M. Jamshedur Rahman, P. Yildiz, Y. Shyr, M. E. Edgerton, M. D. Westfall, J. R. Roberts, J. A. Pietenpol, D. P. Carbone, et al. Significance of p63 Amplification and Overexpression in Lung Cancer Development and Prognosis Cancer Res., November 1, 2003; 63(21): 7113 - 7121. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Imoto, Y. Yuki, I. Sonoda, T. Ito, Y. Shimada, M. Imamura, and J. Inazawa Identification of ZASC1 Encoding a Kruppel-like Zinc Finger Protein as a Novel Target for 3q26 Amplification in Esophageal Squamous Cell Carcinomas Cancer Res., September 15, 2003; 63(18): 5691 - 5696. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, N. Yang, D. Katsaros, W. Huang, J.-W. Park, S. Fracchioli, C. Vezzani, I. A. Rigault de la Longrais, W. Yao, S. C. Rubin, et al. The Oncogene Phosphatidylinositol 3'-Kinase Catalytic Subunit {alpha} Promotes Angiogenesis via Vascular Endothelial Growth Factor in Ovarian Carcinoma Cancer Res., July 15, 2003; 63(14): 4225 - 4231. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Worsham, G. Pals, J. P. Schouten, R. M. L. van Spaendonk, A. Concus, T. E. Carey, and M. S. Benninger Delineating Genetic Pathways of Disease Progression in Head and Neck Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, July 1, 2003; 129(7): 702 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Estilo, P. O-charoenrat, I. Ngai, S. G. Patel, P. G. Reddy, S. Dao, A. R. Shaha, D. H. Kraus, J. O. Boyle, R. J. Wong, et al. The Role of Novel Oncogenes Squamous Cell Carcinoma-related Oncogene and Phosphatidylinositol 3-Kinase p110{alpha} in Squamous Cell Carcinoma of the Oral Tongue Clin. Cancer Res., June 1, 2003; 9(6): 2300 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sawyer, J. Sturge, D. C. Bennett, M. J. O'Hare, W. E. Allen, J. Bain, G. E. Jones, and B. Vanhaesebroeck Regulation of Breast Cancer Cell Chemotaxis by the Phosphoinositide 3-Kinase p110{delta} Cancer Res., April 1, 2003; 63(7): 1667 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Redon, T. Hussenet, G. Bour, K. Caulee, B. Jost, D. Muller, J. Abecassis, and S. d. Manoir Amplicon Mapping and Transcriptional Analysis Pinpoint Cyclin L as a Candidate Oncogene in Head and Neck Cancer Cancer Res., November 1, 2002; 62(21): 6211 - 6217. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Massion, W.-L. Kuo, D. Stokoe, A. B. Olshen, P. A. Treseler, K. Chin, C. Chen, D. Polikoff, A. N. Jain, D. Pinkel, et al. Genomic Copy Number Analysis of Non-small Cell Lung Cancer Using Array Comparative Genomic Hybridization: Implications of the Phosphatidylinositol 3-Kinase Pathway Cancer Res., July 1, 2002; 62(13): 3636 - 3640. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujii, T. Dracheva, A. Player, S. Chacko, R. Clifford, R. L. Strausberg, K. Buetow, N. Azumi, W. D. Travis, and J. Jen A Preliminary Transcriptome Map of Non-Small Cell Lung Cancer Cancer Res., June 1, 2002; 62(12): 3340 - 3346. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |